pd 98059 has been researched along with Dysmyelopoietic Syndromes in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
da Costa, SV | 1 |
Roela, RA | 1 |
Junqueira, MS | 1 |
Arantes, C | 1 |
Brentani, MM | 1 |
Koschmieder, S | 1 |
Hofmann, WK | 1 |
Kunert, J | 1 |
Wagner, S | 1 |
Ballas, K | 1 |
Seipelt, G | 1 |
Hoelzer, D | 1 |
Ottmann, OG | 1 |
Kalina, U | 1 |
2 other studies available for pd 98059 and Dysmyelopoietic Syndromes
Article | Year |
---|---|
The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes.
Topics: Anthracenes; Bone Marrow Cells; Cells, Cultured; Child; Child, Preschool; Female; Flavonoids; Humans | 2010 |
TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.
Topics: Acute Disease; Adult; Antigens, CD34; Cell Division; Disease Progression; DNA Replication; DNA-Bindi | 2001 |